for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Regencell Bioscience Holdings Ltd

RGC.N

Latest Trade

20.30USD

Change

-1.89(-8.52%)

Volume

426

Today's Range

20.30

 - 

21.75

52 Week Range

7.14

 - 

58.75

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
22.19
Open
21.75
Volume
426
3M AVG Volume
15.84
Today's High
21.75
Today's Low
20.30
52 Week High
58.75
52 Week Low
7.14
Shares Out (MIL)
12.97
Market Cap (MIL)
259.73
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Regencell Bioscience Holdings Ltd Announces Pricing Of ~$21.9 Mln IPO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Industry

Business Services

Contact Info

11/F First Commercial Building

33-35 Leighton Roa

999077

Hong Kong

+852.null.21550823

https://www.regencellbioscience.com/

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up